+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

B

Actively Recruiting

This research aims to understand how brain activity relates to anxiety symptoms in autistic youth aged 8 to 14 from underserved communities. It investigates whether changes in brain activity align with improvements in anxiety after a cognitive behavioral therapy called Facing Your Fears FYF. The study also explores how brain activity connects with other anxiety-related factors such as handling uncertainty and managing emotions. Participants are randomly assigned to one of two groups. One group receives the FYF intervention immediately, which is a 12-14 week outpatient group therapy involving weekly 90-minute sessions for autistic youth and their caregivers. The other group continues their usual treatment during a waitlist period and can participate in the FYF program afterward. The FYF program focuses on psychoeducation and cognitive behavioral techniques to help manage anxiety. Throughout the study, participants will undergo assessments including brain activity measurements using EEG, anxiety symptom questionnaires completed by youth and parents, and other tools measuring behavior and emotional regulation. These assessments occur before treatment and within two weeks after the intervention ends. Researchers will also monitor treatment adherence during each session. The total participation spans up to approximately 14 weeks from the first intervention session.

Age: 8Years - 14YearsAll GendersPhase Not Applicable
2 locations
O

Actively Recruiting

Researchers are studying children with Residual Speech Sound Disorders RSSD to see if perceptual training can improve their speech perception and production, specifically focusing on the r sound. The study aims to understand if a childs ability to produce and perceive speech sounds before treatment affects how well they respond to different types of speech therapy. Two treatment orders, starting with either perception training or production training, will be compared to see which helps more depending on the childs initial speech skills. Participants will be randomly assigned to one of two groups receiving treatment via telepractice one group begins with perception training combined with usual treatment, and the other starts with usual treatment before perception training. Treatments include visual acoustic biofeedback, which uses visual displays to help children adjust speech production, and computerized auditory perception tasks. Some participants will also experience a no-treatment period. Randomization is carefully balanced based on participants initial speech production and perception accuracy. Children will complete evaluations before treatment to assess their speech and perception abilities. Throughout the study, researchers will measure improvements in producing the r sound, perception accuracy, and socio-emotional well-being at baseline, after four weeks of biofeedback, and after twelve weeks of treatment. The study involves telepractice sessions, and progress will be monitored using clinician ratings and computerized tasks. The total duration includes baseline assessments and treatment periods lasting up to 12 weeks.

Age: 8Years - 17YearsAll GendersPhase Not Applicable
1 location
E

Actively Recruiting

Healthy Volunteer

This research aims to evaluate the Shield blood tests performance for colorectal cancer CRC screening in people aged 45 to 81 who are at average risk for CRC. The study focuses on assessing the test during a second round of screening, using colonoscopy as the reference standard. CRC is a common and serious disease, especially affecting older adults and certain minority groups, with early detection being key to improving outcomes. Participants will undergo the Shield blood test as part of their routine standard care, and their results will be compared to colonoscopy findings. This study is observational and collects real-world evidence over a period of 33 to 42 months after enrollment to assess how well the Shield test performs in detecting CRC or its precursors during the second screening interval. Participants will be involved in scheduled study procedures and standard care assessments, with data collected on the tests accuracy and effectiveness over time. The main outcome measured is the performance of the Shield test during the second testing period. The study will continue until December 2030, monitoring participants to gather long-term information about CRC screening efficacy in an average-risk population.

Age: 45Years - 81YearsAll Genders
69 locations